One of these patients had been recurrence free for >5 years after resection of a pT3, pN0 moderately differentiated sigmoid adenocarcinoma when he presented with elevated alkaline phosphatase and a new obstructive lesion of the right and common hepatic ducts.
He has been receiving adjuvant capecitabine plus oxaliplatin, and he has been recurrence-free for 5 months since the lymph node resection.
The patient has been recurrence-free for 44 months following surgery, and her appearance during the process is shown in Fig. 3a c.
Through a division of the lesion into three side-by-side dose matrices and applying a marginal and maximal SRS dose of 12 Gy and 24 Gy, respectively, the patient has experienced tumor regression and has been recurrence-free over a 5-year period.
In addition, 104 cases were confirmed to have postoperative recurrence or death within 5 years, whereas 106 cases were confirmed to have been recurrence-free for 5 10 years.
And then just today there has been a recurrence of the 7.85″ iPads we first heard about in October.
There has been no recurrence, however she continues to complain of jaw pain.
There has been no recurrence in uveitis or CNVM till date.
As of 7 months after surgery, there has been no recurrence.
There has been no recurrence at 23 months of follow-up after surgery.
There has been no recurrence in symptomology reported as of time of writing.
